Loading...
Loading...

A federal judge in Texas has paused a high-stakes lawsuit seeking to ban the abortion drug mifepristone nationwide, delaying any ruling until at least December first—giving the FDA crucial time to complete its safety review. The case, filed by Florida and Texas attorneys general in December, aims to nullify the FDA’s 2000 approval and undo subsequent access expansions, threatening nationwide unavailability regardless of state laws. The judge denied a motion to dismiss from the drug’s manufacturers, who stand ready to defend its safety and effectiveness. This is one of three major federal cases targeting mifepristone access—and uniquely invokes the 1873 Comstock Act, resurrecting a long-dormant law banning abortion-related mailings. With elections looming, the legal battle could reshape abortion access across America.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/c9d33711238454d3
No transcript available for this episode.

Anchorage News Today | 2 Min News | The Daily News Now!

Anchorage News Today | 2 Min News | The Daily News Now!

Anchorage News Today | 2 Min News | The Daily News Now!